![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1351020
¼¼°èÀÇ ÅÂ¾Æ ÀüÀÚ ½ÉÀüµµ(FECG) ¸ð´ÏÅÍ ½ÃÀå(2023-2030³â)Global Fetal Electronic Cardiodiagram (FECG) Monitors Market 2023-2030 |
¼¼°è FECG ¸ð´ÏÅÍ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.0%ÀÇ ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¼¼°è ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ °úµµÇÑ ÁöÃâ°ú ÇÔ²² ÅÂ¾Æ ¸ð´ÏÅ͸µ°ú ±× ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °ÍÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ÀüÀÚ ÅÂ¾Æ ¸ð´ÏÅ͸µÀº ¾Æ±âÀÇ ½ÉÀå ¹Úµ¿À» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ºÐ¸¸ Áß ¾Æ±â°¡ »ê¼Ò ºÎÁ·¿¡ ºüÁöÁö ¾Êµµ·Ï Çϱâ À§ÇØ ÀÚÁÖ »ç¿ëµË´Ï´Ù. µû¶ó¼ ÀÇ·á Á¢±Ù¼ºÀÌ °³¼±µÇ°í ÀÖ´Â ½ÅÈï±¹¿¡¼´Â ÷´Ü ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 2¿ù, Àεµ ºñÇϸ£ÁÖ Áö¿ª º´¿ø¿¡¼ ¸ð¿ä ÅÂ¾Æ ½É¹Ú¼ö ¸ð´ÏÅÍ(FHRM)ÀÇ µµÀÔ °¡´É¼ºÀ» Á¶»çÇϱâ À§ÇÑ ¿¬±¸°¡ ÁøÇàµÇ¾ú½À´Ï´Ù. ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº Moyo FHRM µµÀÔÀÇ À庮°ú ÃËÁø¿äÀÎÀ» ÆÄ¾ÇÇÏ°í »ê°ú ¹× ½Å»ý¾Æ °á°ú µ¥ÀÌÅÍÀÇ ½Å·Ú¼ºÀ» Æò°¡ÇÏ´Â °ÍÀ̾ú½À´Ï´Ù.
ÈÞ´ë¿ë ÇÏÀ§ ºÎ¹® Áß¿¡¼µµ °íÁ¤Çü ÇÏÀ§ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â ÆíÀǼº ¶§¹®¿¡ º´¿ø¿¡¼ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÷´Ü ÀÇ·á ½Ã¼³¿¡¼ °íÁ¤Çü ÅÂ¾Æ ¸ð´ÏÅʹ žÆÀÇ °Ç° »óŸ¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â µ¥ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù. µû¶ó¼ ÀϺΠÁÖ¿ä ÀÇ·á ±â°üÀº ¾÷±×·¹À̵åµÇ°í Àß °®Ãß¾îÁø ±â¼ú ¸ð´ÏÅ͸¦ ÅëÇÕÇϱâ À§ÇØ ¿©·¯ ÁÖ¿ä ÀÇ·á ±â°üÀ» ¹Ð¾î ºÙ¿´½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â GEÇコÄɾî´Â Novii Wireless °íÁ¤½Ä FECG ¸ð´ÏÅ͸¦ Á¦°øÇϱ⠽ÃÀÛÇßÀ¸¸ç, Novii Wireless Patch SystemÀº ÀӽŠÁß FHRÀ» ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëµÇ´Â FECG ¸ð´ÏÅ͸µ ÀåÄ¡ÀÔ´Ï´Ù. žÆÀÇ ½É¹Ú¼ö¸¦ ºÐ¼®ÇÏ´Â ºñħ½ÀÀûÀÎ ¹æ¹ýÀ» Á¦°øÇÏ¿© žÆÀÇ ¼ºÀå°ú °Ç°À» º¸¿©ÁÝ´Ï´Ù. »õ·Î µµÀÔµÈ ½Ã½ºÅÛÀº ÅÂ¾Æ ½É¹Ú¼ö, ¸ðü ½É¹Ú¼ö, Àڱà Ȱµ¿À» ºñħ½ÀÀûÀ¸·Î ÃøÁ¤Çϰí Ç¥½ÃÇÏ´Â ¸ðü-ÅÂ¾Æ ¸ð´ÏÅÍÀÔ´Ï´Ù.
ÅÂ¾Æ ÀüÀÚ ½ÉÀüµµ(FECG) ¸ð´ÏÅÍ ¼¼°è ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹ ¹× ij³ª´Ù), À¯·´(ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º, ±âŸ), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ), ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì)À» Æ÷ÇÔÇÑ Áö¸®Àû Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐȵ˴ϴÙ. ±¸ºÐµË´Ï´Ù. ±× Áß¿¡¼µµ À¯·´ ½ÃÀåÀº ÀÇ·á ÀÎÇÁ¶ó°¡ Àß ±¸ÃàµÇ¾î ÀÖ°í, ¼±Áø ÀÇ·á ±â¼ú µµÀÔÀÌ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ¾î ¿¹Ãø ±â°£ µ¿¾È Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ½Ã¼³ÀÇ Áö¼ÓÀûÀÎ °³¼±°ú ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ ÅÂ¾Æ ½ÉÀüµµ(FECG) ¸ð´ÏÅÍ ¼¼°è ½ÃÀå¿¡¼ Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÏ¹Ì°¡ ¼¼°è ÅÂ¾Æ ½ÉÀüµµ(FECG) ¸ð´ÏÅÍ ½ÃÀå¿¡¼ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ FECG ¸ð´ÏÅÍ ½ÃÀåÀÇ ¼ºÀåÀº ÁÖ·Î ÀÇ·á Áø·á¿¡¼ ÅÂ¾Æ ¸ð´ÏÅ͸µÀÇ »ó´ëÀûÀ¸·Î ³ôÀº º¸±Þ·ü°ú °í±Þ ÀÇ·á ½Ã¼³ÀÇ Á¸Àç¿¡ ÀÇÇØ °ÈµÇ°í ÀÖ½À´Ï´Ù.
Title: Global Fetal Electronic Cardiodiagram (FECG) Monitors Market Size, Share & Trends Analysis Report by Type (Portable and Stationary), by Application (Hospitals, Clinics, and Home Use), by Technology (Direct Contact and Non-contact), and by End-User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies),Forecast Period (2023-2030).
The global FECG monitors market is projected to grow at a significant CAGR of 7.0% during the forecast period. The primary factor supporting the market expansion includes the rising awareness about fetal monitoring and its benefits along with excessive spending in healthcare infrastructure around the globe. Electronic fetal monitoring continuously monitors a baby's heartbeat, often used during labor to ensure that babies do not lack of oxygen during labor, as it results in brain damage. Consequently, there is a considerable increase in demand for advanced monitoring devices several in emerging economies where healthcare access is improving. For instance, in February 2021, a study was conducted in order to investigate the feasibility of implementing the Moyo fetal heart rate monitor (FHRM) in district hospitals of Bihar state, India. The study aimed to identify the barriers and facilitators for the implementation of Moyo FHRM and assess the reliability of obstetrical and neonatal outcome data.
The global fetal electronic cardiodiagram (FECG) monitors market is categorized based on its type, application, technology, and end-user segments. Based on its type, the market is divided into portable and stationary. When considering the application, the market segments include hospitals, clinics, and home use. Moreover, the market is further divided based on technology which includes direct contact and non-contact categories. Based on the end-user, the market is sub-segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Among the type segment, portable sub-segment is anticipated to capture a substantial market share, owing to its extraordinary convenience of remote operating.
Among the portable sub-segment, the stationary sub-segment is expected to experience significant growth during the forecast period. This growth is attributed to factors including the increased adoption of such monitors in hospital settings owing to its convenience offered. In advanced medical facilities, stationary fetal monitors are essential tools for continuous monitoring of fetal health. Thus, pushed several major healthcare organizations to integrate upgraded and well-equipped technological monitors. For instance, in 2022. GE Healthcare started providing Novii Wireless stationary FECG monitors. The Novii Wireless Patch System is a FECG monitoring device used for monitoring the FHR during pregnancy. They provide a non-invasive method of analyzing the fetal heart rate, indicating the growth and well-being of the fetus. The newly introduced system is a maternal/fetal monitor that non-invasively measures and displays fetal heart rate, maternal heart rate, and uterine activity.
The global fetal electronic cardiodiagram (FECG) monitors market is further segmented based on geographical regions, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Europe market is expected to experience substantial growth over the forecast period owing to well-established healthcare infrastructure coupled with the increasing adoption of advanced medical technologies. Meanwhile, the Asia-Pacific region is projected to witness considerable growth in the global fetal electronic cardiodiagram (FECG) monitors market, driven by continuously improving healthcare facilities and rising healthcare spending.
The North American region is expected to hold a significant share in the global fetal electronic cardiodiagram (FECG) monitors market. The regional FECG monitor market growth is primarily bolstering due to a comparatively high prevalence of fetal monitoring in healthcare practices and the presence of advanced medical facilities.
Major companies operating in the global FECG Monitors market include: FUJIFILM Corp., GE HealthCare Technologies Inc., Mindray, Koninklijke Philips N.V., Siemens Healthineers, and others. These market players are actively contributing to market growth through various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, in order to maintain their competitiveness in the market. For instance, in July 2021, in partnership with PeriGen, the Texas Children's Pavilion for Women has undertaken a project to implement the PeriWatch Vigilance automated early warning system within a hospital located in Malawi, Africa. This innovative system is designed to consistently monitor maternal and fetal information, aiming to avert potential complications and reduce childbirth-related fatalities.